BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 18004727)

  • 1. Dose-dependent differential upregulation of CCN1/Cyr61 and CCN3/NOV by the gap junction protein Connexin43 in glioma cells.
    Sin WC; Bechberger JF; Rushlow WJ; Naus CC
    J Cell Biochem; 2008 Apr; 103(6):1772-82. PubMed ID: 18004727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCN3 (NOV) interacts with connexin43 in C6 glioma cells: possible mechanism of connexin-mediated growth suppression.
    Fu CT; Bechberger JF; Ozog MA; Perbal B; Naus CC
    J Biol Chem; 2004 Aug; 279(35):36943-50. PubMed ID: 15213231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of a potential role of the CCN family of growth regulators in connexin43 transfected C6 glioma cells.
    McLeod TL; Bechberger JF; Naus CC
    Cell Commun Adhes; 2001; 8(4-6):441-5. PubMed ID: 12064632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased invasive capacity of connexin43-overexpressing malignant glioma cells.
    Zhang W; Nwagwu C; Le DM; Yong VW; Song H; Couldwell WT
    J Neurosurg; 2003 Dec; 99(6):1039-46. PubMed ID: 14705732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of glioma cell growth and tumorigenic potential by CCN3 (NOV).
    Gupta N; Wang H; McLeod TL; Naus CC; Kyurkchiev S; Advani S; Yu J; Perbal B; Weichselbaum RR
    Mol Pathol; 2001 Oct; 54(5):293-9. PubMed ID: 11577170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Connexin43 enhances glioma invasion by a mechanism involving the carboxy terminus.
    Bates DC; Sin WC; Aftab Q; Naus CC
    Glia; 2007 Nov; 55(15):1554-64. PubMed ID: 17823969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Communication between malignant glioma cells and vascular endothelial cells through gap junctions.
    Zhang W; DeMattia JA; Song H; Couldwell WT
    J Neurosurg; 2003 Apr; 98(4):846-53. PubMed ID: 12691411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Connexin 43 enhances the adhesivity and mediates the invasion of malignant glioma cells.
    Lin JH; Takano T; Cotrina ML; Arcuino G; Kang J; Liu S; Gao Q; Jiang L; Li F; Lichtenberg-Frate H; Haubrich S; Willecke K; Goldman SA; Nedergaard M
    J Neurosci; 2002 Jun; 22(11):4302-11. PubMed ID: 12040035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in the synthesis of insulin-like growth factor binding proteins and insulin-like growth factors in rat C6 glioma cells transfected with a gap junction connexin43 cDNA.
    Bradshaw SL; Naus CC; Zhu D; Kidder GM; D'Ercole AJ; Han VK
    Regul Pept; 1993 Oct; 48(1-2):99-112. PubMed ID: 7505471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Connexin43 interacts with NOV: a possible mechanism for negative regulation of cell growth in choriocarcinoma cells.
    Gellhaus A; Dong X; Propson S; Maass K; Klein-Hitpass L; Kibschull M; Traub O; Willecke K; Perbal B; Lye SJ; Winterhager E
    J Biol Chem; 2004 Aug; 279(35):36931-42. PubMed ID: 15181016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Connexin43 suppresses MFG-E8 while inducing contact growth inhibition of glioma cells.
    Goldberg GS; Bechberger JF; Tajima Y; Merritt M; Omori Y; Gawinowicz MA; Narayanan R; Tan Y; Sanai Y; Yamasaki H; Naus CC; Tsuda H; Nicholson BJ
    Cancer Res; 2000 Nov; 60(21):6018-26. PubMed ID: 11085522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of connexin43-interacting proteins at gap junctions.
    Giepmans BNG
    Adv Cardiol; 2006; 42():41-56. PubMed ID: 16646583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estradiol Receptors Regulate Differential Connexin 43 Expression in F98 and C6 Glioma Cell Lines.
    Moinfar Z; Dambach H; Schoenebeck B; Förster E; Prochnow N; Faustmann PM
    PLoS One; 2016; 11(2):e0150007. PubMed ID: 26919293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced connexin43 expression in high-grade human brain glioma cells.
    Huang RP; Hossain MZ; Sehgal A; Boynton AL
    J Surg Oncol; 1999 Jan; 70(1):21-4. PubMed ID: 9989416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opposing roles of connexin43 in glioma progression.
    Sin WC; Crespin S; Mesnil M
    Biochim Biophys Acta; 2012 Aug; 1818(8):2058-67. PubMed ID: 22063721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCN1 (CYR61) and CCN3 (NOV) signaling drives human trophoblast cells into senescence and stimulates migration properties.
    Kipkeew F; Kirsch M; Klein D; Wuelling M; Winterhager E; Gellhaus A
    Cell Adh Migr; 2016 Mar; 10(1-2):163-78. PubMed ID: 26744771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. More insights into the CCN3/Connexin43 interaction complex and its role for signaling.
    Gellhaus A; Wotzlaw C; Otto T; Fandrey J; Winterhager E
    J Cell Biochem; 2010 May; 110(1):129-40. PubMed ID: 20336664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of the CCN family members Cyr61, CTGF and Nov in human breast cancer.
    Jiang WG; Watkins G; Fodstad O; Douglas-Jones A; Mokbel K; Mansel RE
    Endocr Relat Cancer; 2004 Dec; 11(4):781-91. PubMed ID: 15613452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyr61 is overexpressed in gliomas and involved in integrin-linked kinase-mediated Akt and beta-catenin-TCF/Lef signaling pathways.
    Xie D; Yin D; Tong X; O'Kelly J; Mori A; Miller C; Black K; Gui D; Said JW; Koeffler HP
    Cancer Res; 2004 Mar; 64(6):1987-96. PubMed ID: 15026334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutated connexin43 proteins inhibit rat glioma cell growth suppression mediated by wild-type connexin43 in a dominant-negative manner.
    Omori Y; Yamasaki H
    Int J Cancer; 1998 Nov; 78(4):446-53. PubMed ID: 9797133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.